Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Omthera Pharmaceuticals

- PMLiVE

AZ’s Mene Pangalos joins Precision Medicine Catapult board

Has also been appointed a fellow at the University of Cambridge

- PMLiVE

GSK and AZ drugs impress in lupus trials

Raises hope for better treatment for debilitating disease

- PMLiVE

AZ boosts cardio-renal portfolio with $2.7bn ZS Pharma buy

Acquires rights to potential best-in-class treatment for hyperkalaemia

- PMLiVE

AstraZeneca backs heart website

Works with charity HEART UK on How Young My Heart

- PMLiVE

AZ moves a step closer to gout drug approval in US

Final verdict to be delivered in end of December

Eli Lilly HQ

Lilly and AZ forge closer immuno-oncology bond

Look to boost their presence in a market predicted to be worth $30bn in 10 years

- PMLiVE

FDA rejects AZ’s diabetes combination

Wants to see more trial data on saxagliptin / dapagliflozin

- PMLiVE

AZ halts durvalumab combination trials on safety grounds

Saysmove is a precautionary step after respiratory disease reports

- PMLiVE

Novartis’ Cosentyx effective in psoriatic arthritis study

Further supports drugs ability to reduce progression of damage to joints

- PMLiVE

AZ opens new research centre with Cancer Research UK

MedImmune partners with CRUK in Cambridge-based R&D hub

AZ signs £11.5m bioinformatics deal with Manchester University

Five-year programme will focus on personalised health research

- PMLiVE

FDA approval keeps AZ on track with ambitious Brilinta plans

Receives additional indication for use in heart attack patients

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links